DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

DHP Korea (KOSDAQ:131030) has had a rough month with its share price down 3.3%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on DHP Korea's ROE.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.

See our latest analysis for DHP Korea

Advertisement

How To Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for DHP Korea is:

13% = ₩15b ÷ ₩116b (Based on the trailing twelve months to September 2020).

The 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each ₩1 of shareholders' capital it has, the company made ₩0.13 in profit.

What Has ROE Got To Do With Earnings Growth?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

DHP Korea's Earnings Growth And 13% ROE

At first glance, DHP Korea seems to have a decent ROE. Even when compared to the industry average of 11% the company's ROE looks quite decent. Consequently, this likely laid the ground for the decent growth of 5.8% seen over the past five years by DHP Korea.

Next, on comparing with the industry net income growth, we found that DHP Korea's reported growth was lower than the industry growth of 11% in the same period, which is not something we like to see.

past-earnings-growth
KOSDAQ:A131030 Past Earnings Growth February 11th 2021

Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is DHP Korea fairly valued compared to other companies? These 3 valuation measures might help you decide.

Is DHP Korea Efficiently Re-investing Its Profits?

Summary

In total, we are pretty happy with DHP Korea's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see a good amount of growth in its earnings.

If you decide to trade DHP Korea, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About KOSDAQ:A131030

OPTUS Pharmaceutical

Provides ophthalmic solutions in South Korea.

Flawless balance sheet with acceptable track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0776.1% undervalued
210 users have followed this narrative
1 users have commented on this narrative
30 users have liked this narrative
SI
SimpleMan887
GME logo
SimpleMan887 on GameStop ·

GameStop will ace the financial crisis wave with its strategic Bitcoin investment and cash reserves

Fair Value:US$22089.6% undervalued
53 users have followed this narrative
2 users have commented on this narrative
21 users have liked this narrative
YI
HSAI logo
yiannisz on Hesai Group ·

The First Real Lidar Winner

Fair Value:US$27.0719.6% undervalued
14 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
TR
tripledub
TSM logo
tripledub on Taiwan Semiconductor Manufacturing ·

The Most Wonderful Monopoly in the Most Dangerous Neighbourhood on Earth

Fair Value:US$3814.1% undervalued
10 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
9556 logo
AstrisCorporateAdvisory on INTLOOP ·

Renewed focus on business investment

Fair Value:JP¥4.17k56.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GO
NLBR logo
GoranLagea on Nova Ljubljanska Banka d.d ·

Nova Ljubljanska Banka d.d. future looks bright with a profit margin change of 38%

Fair Value:€36036.7% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FA
FIBRO logo
FA_Trader on Fibromat (M) Berhad ·

Fibromat: More than just a niche player, with clearer earnings visibility from order book and project wins

Fair Value:RM 1.0519.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3955.6% undervalued
44 users have followed this narrative
3 users have commented on this narrative
41 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
36 users have followed this narrative
11 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3136.5% undervalued
1348 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative